Related Experiment Video
Updated: May 9, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway
Partha Chakrabarti1, Ju Youn Kim, Maneet Singh
1Boston University School of Medicine, Boston, Massachusetts, USA. pc1@csiriicb.in
Abstract:
One of the basic functions of insulin in the body is to inhibit lipolysis in adipocytes. Recently, we have found that insulin inhibits lipolysis and promotes triglyceride storage by decreasing transcription of adipose triglyceride lipase via the mTORC1-mediated pathway (P. Chakrabarti et al., Diabetes 59:775-781, 2010), although the mechanism of this effect remained unknown. Here, we used a genetic screen in Saccharomyces cerevisiae in order to identify a transcription factor that mediates the effect of Tor1 on the expression of the ATGL ortholog in yeast. This factor, Msn4p, has homologues in mammalian cells that form a family of early growth response transcription factors. One member of the family, Egr1, is induced by insulin and nutrients and directly inhibits activity of the ATGL promoter in vitro and expression of ATGL in cultured adipocytes. Feeding animals a high-fat diet increases the activity of mTORC1 and the expression of Egr1 while decreasing ATGL levels in epididymal fat. We suggest that the evolutionarily conserved mTORC1-Egr1-ATGL regulatory pathway represents an important component of the antilipolytic effect of insulin in the mammalian organism.
Insights
Insulin inhibits fat breakdown by reducing adipose triglyceride lipase (ATGL) transcription. A conserved mTORC1-Egr1 pathway mediates this effect, revealing a key mechanism for insulin
Area of Science:
- Molecular biology
- Cell biology
- Metabolic regulation
Background:
- Insulin's role in inhibiting lipolysis (fat breakdown) in adipocytes is crucial for triglyceride storage.
- Previous studies identified the mTORC1 pathway's involvement in reducing adipose triglyceride lipase (ATGL) transcription, but the precise mechanism was unclear.
Purpose of the Study:
- To identify the transcription factor mediating the effect of Tor1 on ATGL ortholog expression in yeast.
- To elucidate the molecular mechanism by which insulin inhibits lipolysis in mammalian cells.
Main Methods:
- Genetic screen in Saccharomyces cerevisiae to identify transcription factors.
- In vitro assays to assess ATGL promoter activity.
- Experiments using cultured adipocytes and animal models (high-fat diet).
Main Results:
- A yeast transcription factor, Msn4p, was identified as mediating Tor1's effect on ATGL ortholog expression.
- Msn4p homologues in mammals include early growth response transcription factors, such as Egr1.
- Egr1 is induced by insulin and nutrients, directly inhibits ATGL promoter activity, and reduces ATGL expression in adipocytes.
- High-fat diet increases mTORC1 activity and Egr1 expression while decreasing ATGL levels in epididymal fat.
Conclusions:
- The mTORC1-Egr1-ATGL regulatory pathway is evolutionarily conserved.
- This pathway is a significant component of insulin's antilipolytic effect in mammals.
- Understanding this pathway offers insights into metabolic regulation and triglyceride storage.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
PI3K/mTOR/AKT Signaling Pathway
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
cAMP-dependent Protein Kinase Pathways
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
